Welcome to our dedicated page for Costas news (Ticker: CSSI), a resource for investors and traders seeking the latest updates and insights on Costas stock.
The CSSI news archive on Stock Titan covers the public communications of Costas, Inc., which did business as Standard Dental Labs Inc. in the dental lab and dental prosthetics sector. These news items document the company’s transition toward a focused dental laboratory business, its acquisition strategy, and its later rebranding and ticker symbol change to Standard Dental Labs Inc. with the symbol TUTH after an interim period under CSSID.
Readers can find press releases describing the company’s efforts to acquire and consolidate privately owned dental labs, particularly in Florida and the Orlando area. The news flow includes updates on acquisitions such as Prime Dental Lab, commentary on consolidation trends in the dental lab industry, and the company’s retirement succession program for baby boomer dental lab owners seeking an exit or transition.
Other articles highlight regulatory and capital markets developments. These include the filing of annual reports, work with auditors and regulators, efforts to restore FINRA compliance, the rescinding of a cease trade order in Canada, and the filing of a Tier 2 Regulation A offering to support expansion in Florida’s dental lab market. The company also reports on investments in equipment and automation, such as upgrades to 3D milling and related lab infrastructure.
More recent releases describe the formal name change from Costas, Inc. to Standard Dental Labs Inc., a reverse stock split, and the shift from the CSSI ticker to CSSID and then to TUTH. Investors and researchers can use this news page to trace how the business focus, regulatory status, and corporate identity evolved over time. For ongoing developments after the symbol transition, users should also review news associated with the updated ticker.
Costas, Inc. (OTC PINK:CSSI) reports Q3 2022 gross revenues of $44,770, attributed to its acquisition of assets from Prime Dental Labs effective September 1, 2022. This marks the Company's first revenues under new management. The company has also filed a supplemental notice indicating it is no longer a 'Shell Company.' Furthermore, it aims to acquire additional dental labs in Orlando, positioning itself in a US dental lab market projected at $10B, with plans for consolidation into larger operational facilities.
Costas, Inc. (CSSI) has engaged an Independent Registered Public Accounting Firm to audit its financial results for the fiscal years 2021 and 2020, and for the six-month interim periods ending June 30, 2022, and 2021. This follows the recent agreement to acquire Prime Dental Lab LLC's assets. The audits will adhere to US GAAP, focusing on revenue recognition. The company aims to become a fully reporting issuer with the SEC and plans to complete audits to file a Form S-1 Registration. The dental lab market is expected to grow to $43.5 billion by 2028, presenting acquisition opportunities for CSSI.
Costas, Inc. (OTC PINK:CSSI) has finalized an agreement to acquire Prime Dental Lab, LLC, an Orlando-based dental lab with over a decade of operation and 2021 unaudited gross revenue surpassing $600,000. The deal, valued at $700,000, will be executed through a mix of cash and registered shares, with shares held in escrow for two years. This acquisition aligns with CSSI's strategy to consolidate dental labs for operational efficiencies within the $10B U.S. dental lab market, focusing on cash-flowing and profitable businesses.
Costas, Inc. (CSSI) has announced the formal acquisition agreement of Standard Dental Labs Inc. (SDL), following unanimous shareholder approval on February 28, 2022. This strategic move marks CSSI's entry into the $10B dental lab industry, focusing on consolidating small to medium-sized dental labs, which are currently fragmented across the U.S. The acquisition is expected to enhance economies of scale and competitiveness in the market. CEO James Brooks emphasized the rapid growth potential through acquisition, aiming to establish CSSI as a leader in the dental lab sector.
Costas, Inc. (OTCMKTS:CSSI) has announced an acquisition offer to the shareholders of Standard Dental Labs Inc. (SDL), aiming to consolidate dental labs in the private sector. This strategic move targets a long-term growth trajectory in the $10B US dental lab market, which is projected to expand due to rising demand from the retirement community. Recent studies highlight the challenges faced by aging small business owners, presenting consolidation as a viable option for operational efficiency. The acquisition could enhance competitiveness through advanced equipment investments.